Skip to main content

Table 3 Association between different status of sarcopenia, and RAGE in gender difference using linear regression analysis

From: Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study

Gender Variables RAGE
Crude β coefficients
(95% CI)
P Value Adjusted β coefficients
(95% CI)
P Value
All Probable −95.63 (− 343.44, 152.18) 0.448 −76.05 (−333.16, 181.06) 0.561
Confirmed 436.93 (222.05, 651.82) < 0.001 449.72 (229.39, 670.05) < 0.001
Severe 94.77 (− 173.60, 363.14) 0.488 154.42 (− 132.99, 441.84) 0.291
Male Probable −266.70 (− 844.50, 311.11) 0.363 − 284.20 (− 866.80, 298.41) 0.336
Confirmed 263.85 (−150.26, 677.95) 0.210 154.92 (−291.92, 601.77) 0.494
Severe 62.51 (−280.07, 405.08) 0.719 −52.99 (− 434.77, 328.79) 0.784
Female Probable −75.45 (− 365.88, 214.97) 0.609 20.07 (− 276.95, 317.09) 0.894
Confirmed 478.78 (215.11, 742.45) < 0.001 498.61 (238.77, 758.45) < 0.001
Severe 142.14 (− 281.71, 565.99) 0.509 320.55 (− 113.07, 754.17) 0.146
  1. aAdjusted covariates: age, sex, smoking, comorbidities (hypertension, diabetes mellitus, myocardial infarction, angina, coronary artery disease, and chronic obstructive pulmonary disease)